Cationic Iridium Complexes Research Articles

Structural Rigidification Strategy Based on Self-Assembly Enabled Reversible Excited-State Conversion of Iridium(III) Complexes for Multiple-Stimulus-Responsive Data Encryption.

Stimulus-responsive chromic materials exhibit color-switching properties under specific external stimuli and have been widely used in various fields. Transition-metal complexes show great potential applications as promising candidates for stimulus-responsive chromic materials, as their excited states not only depend on the chemical composition but are also affected by the intermolecular stacking modes. Owing to the intrinsic difficulty in the ordered stacking of the octahedral configuration, changing the stacking modes of iridium(III) complexes for multiple-stimulus responsiveness remains a significant challenge. In this work, we propose a structural rigidification strategy based on self-assembly to reversibly regulate the excited states of iridium(III) complexes, therefore achieving color switch under different stimulus conditions. We prepare cationic iridium(III) complexes by using tetrakis(perfluorophenyl)-borate ([B(PhF5)4]-) as the counterion, whose matching tetrahedral configuration and electron-deficient aromaticity enables polar-π interaction with the octahedral iridium(III) cations, inducing self-assembly to form structural rigidification. The structural rigidity restricts the large conformational changes of the metal-to-ligand charge transfer (3MLCT) excited state, and facilitates the conversion from the 3MLCT to the ligand-center (3LC) excited state in aggregated states. The excited-state conversion results in a 54 nm blue shift (from yellow to sky blue) in the photoluminescence spectra. As a result, we report a series of cationic iridium(III) complexes with different responses to low temperature, vapor fuming, and mechanical force, therefore achieving multiple-stimulus-responsive data encryption. Our work provides a novel strategy to achieve ordered stacking of octahedral complexes, shows a deeper understanding of the photophysical processes of transition-metal complexes, and offers a new perspective to develop multiple-stimulus-responsive chromic materials.

Cationic Iridium(III) Complexes Bearing Different Bulky N,N′-Chelating Ligands

Six cationic iridium(III) complexes bearing different bulky N,N′-chelating ligands were successfully synthesized and characterized by spectroscopic, electrochemical, thermal and photophysical methods. Because the molecular quenching and self-aggregation within molecules would deteriorate the device efficiency, the bulky molecules can suppress these problems and improve the device performance. The best doped organic light-emitting diodes based on these charged Ir(III) complex E1 exhibited Lmax of 26,800 cd/m2, ηL, max of 35.0 cd/A and ηP, max of 18.5 lm/W, which also showed a small efficiency roll-off in the range of 100 to 1000 cd/m2.Graphical

Deprotonation-induced changes in π-electron systems of iridium(III) and rhodium(III) complexes with azophenine

N,N′,N′′,N′′′-Tetraphenyl-2,5-diamino-1,4-benzoquinonediimines (RAp·H2) are used as unique bridging ligands containing localized π-electron systems at each of the two NCCCNH moieties, which are susceptible to changes on coordination of the N atoms to Lewis acid(s). In this contribution, we disclose deprotonation-induced changes in the π-electron systems, spectroscopic properties, and electronic state of cationic cyclometalated iridium(III) and rhodium(III) complexes with 4-EtAp·H2, i.e., [M(ppy)2(4-EtAp·H2)]Cl (ppy: 2-phenylpyridinate; M: Ir(III) (1·H2+) and Rh(III) (2·H2+)). The cationic complexes possessed localized π-electron systems, but the NCCCNH moieties were isomerized from those in free 4-EtAp·H2. Although 4-EtAp·H2 showed no responsiveness to tetrabutylammonium hydroxide (TBAOH) as a base, the reaction of 1·H2+ and 2·H2+ with TBAOH afforded monodeprotonated neutral complexes [M(ppy)2(4-EtAp·H)] (M: Ir(III) (1·H) and Rh(III) (2·H)). UV–vis absorption spectral titrations of 1·H2+ and 2·H2+ with TBAOH revealed the occurrence of monodeprotonation even in the presence of 4 equivalents of TBAOH. The cationic complexes were regenerated from 1·H and 2·H upon addition of p-toluenesulfonic acid. X-ray crystallography of 2·H showed that the complex has localized and delocalized π-electron systems at the NCCCNH and NCCCN moieties, respectively. The UV–vis absorption spectra of 1·H2+ and 2·H2+ in CH2Cl2 present intense bands around 500 nm, and those of 1·H and 2·H exhibit intense bands around 450 nm and broad bands around 700 nm. Density functional theory (DFT), time-dependent DFT, and natural transition orbital calculations suggest that the intense bands of all complexes and the broad bands of 1·H and 2·H stem from π–π* transitions in the localized and delocalized π-electron systems, respectively, with MLCT transition.

A Ferroptosis‐Inducing Arsenene‐Iridium Nanoplatform for Synergistic Immunotherapy in Pancreatic Cancer

AbstractDue to multidrug resistance and the high risk of recurrence, effective and less toxic alternative pancreatic cancer treatments are urgently needed. Pancreatic cancer cells are highly resistant to apoptosis but sensitive to ferroptosis. In this study, an innovative nanoplatform (AsIr@PDA) was developed by electrostatic adsorption of a cationic iridium complex (IrFN) onto two‐dimensional (2D) arsenene nanosheets. This nanoplatform exhibits superior ferroptosis‐inducing effects with high drug loading capacity and, importantly, excellent anti‐cancer immune activation function, leading to efficient elimination of pancreatic tumors with no observable side effects. Interestingly, AsIr@PDA significantly prevents the recurrence of pancreatic cancer in vivo when compared with a cisplatin‐loaded nanoplatform. This designed nanoplatform demonstrated superior therapeutic efficacy by synergistic ferroptosis‐induced chemotherapy with immunotherapy via an all‐in‐one strategy, providing new insights for future pancreatic cancer therapy.

A Ferroptosis-Inducing Arsenene-Iridium Nanoplatform for Synergistic Immunotherapy in Pancreatic Cancer.

Due to multidrug resistance and the high risk of recurrence, effective and less toxic alternative pancreatic cancer treatments are urgently needed. Pancreatic cancer cells are highly resistant to apoptosis but sensitive to ferroptosis. In this study, an innovative nanoplatform (AsIr@PDA) was developed by electrostatic adsorption of a cationic iridium complex (IrFN) onto two-dimensional (2D) arsenene nanosheets. This nanoplatform exhibits superior ferroptosis-inducing effects with high drug loading capacity and, importantly, excellent anti-cancer immune activation function, leading to efficient elimination of pancreatic tumors with no observable side effects. Interestingly, AsIr@PDA significantly prevents the recurrence of pancreatic cancer in vivo when compared with a cisplatin-loaded nanoplatform. This designed nanoplatform demonstrated superior therapeutic efficacy by synergistic ferroptosis-induced chemotherapy with immunotherapy via an all-in-one strategy, providing new insights for future pancreatic cancer therapy.

Deep-blue light–emitting cationic iridium(III) complexes featuring diamine ancillary ligands: Experimental and theoretical investigations

Deep-blue emitters based on combining two approaches are reported here. In the first approach, the nitrogen content of the cyclometallated ligand is increased using 2,4′-bpy ligands, leading to a low highest occupied molecular orbital energy. In the second approach, 2,2′-bpy is replaced with a lower electron donating ligand, leading to a high lowest unoccupied molecular orbital (LUMO) energy. Thus, three new ionic transition metal complexes of [Ir(2,4′-bpy)2(NN)]PF6 [where NN is 2,2′-bpy (1), o-phenylenediamine (2), and 4-methoxy-o-phenylenediamine (3)] were synthesized, and their electronic and photophysical features were studied. In solution, [Ir(2,4′-bpy)2bpy]PF6 emits blue light centered at 396 nm, which is blue-shifted compared to [Ir(ppy)2bpy]PF6. The low electron donation of the diamine ancillary ligands introduces the contribution of the cyclometallated ligand to the LUMO, changing the nature of the emission and leading to different photophysical features. Density functional theory calculations indicate the long bond distances of Ir–Ns at the diamine ligands, suggesting weak metal–ligand interactions and low quantum yields.11DFT Density functional theory, ECP Effective core potential, FMO Frontier molecular orbitals, HOMO Highest occupied molecular orbital, LEEC Light-emitting electrochemical cells, LUMO Lowest unoccupied molecular orbital, NMR Nuclear magnetic resonance, OLED Organic light-emitting diodes, SCF Self-consistent-field, ILCT Interligand charge transfer, LLCT Ligand to ligand charge transfer, PLQY Photoluminescence quantum yield.

Hybrid nanospheres of silica covalently containing yellow-emitting cationic iridium(III) complex: preparation and application in white light-emitting diodes.

A yellow-emitting cationic iridium(III) complex [(dfppy)2Ir(TBD)]PF6 (TBD: N4,N4'-bis(3-(triethoxysilyl)propyl)-[2,2'-bipyridine]-4,4'-dicarboxamide; dfppy: 2-(2,4-difluorophenyl)pyridine) containing hydrolysable alkoxysilanes was synthesized. Then, a series of silica-based hybrid nanospheres with diameters of around 400 nm was prepared via the hydrolysis of this complex together with tetraethyl orthosilicate (TEOS, a silica source). When the amount of the complex used was 5.0 wt%, hybrid nanospheres showed the best photoluminescence (PL) properties, relative to the PL quantum yield of pure solid [(dfppy)2Ir(TBD)]PF6 (12.7%), that of hybrid nanospheres increased to 26.2%. Moreover, the thermal decomposition temperature (Td) of pure solid [(dfppy)2Ir(TBD)]PF6 was 331 °C, the Td of the complex in hybrid nanospheres increased to 447 °C. However, the yellow light emission was almost unchanged and was still located at 500-750 nm with a maximum wavelength (λem,max) of 577 nm. Under the excitation of blue-emitting chips (λem,max ≈ 455 nm), cold/neutral/warm white light-emitting diodes (WLEDs) with good luminous quality can all be fabricated using these hybrid nanospheres as phosphors in epoxy resin at different blending concentrations. Compared with two or three iridium(III) complexes being contained in silica-based particles as phosphors as described in literatures, in this study, silica-based hybrid nanospheres covalently containing only one yellow-emitting cationic iridium(III) complex as phosphors provide a more effective and simpler method for preparation high-performance WLEDs.

Long-wavelength triggered iridium(III) complex nanoparticles for photodynamic therapy against hypoxic cancer.

A long-wavelength triggered cationic iridium(III) complex, Ir5, and its corresponding nanoparticles with the ability to generate type I and type II reactive oxygen species have been synthesised. The complex targets mitochondria and achieves an excellent photodynamic therapy effect in hypoxic cancer cells.

Mitochondria-targeted neutral and cationic iridium(III) anticancer complexes chelating simple hybrid sp2-N/sp3-N donor ligands.

Most platinum group-based cyclometalated neutral and cationic anticancer complexes with the general formula [(C^N)2Ir(XY)]0/+ (neutral complex: XY = bidentate anionic ligand; cationic complex: XY = bidentate neutral ligand) are notable owing to their intrinsic luminescence properties, good cell permeability, interaction with some biomolecular targets and unique mechanisms of action (MoAs). We herein synthesized a series of neutral and cationic amine-imine cyclometalated iridium(III) complexes using Schiff base ligands with sp2-N/sp3-N N^NH2 chelating donors. The cyclometalated iridium(III) complexes were identified by various techniques. They were stable in aqueous media, displayed moderate fluorescence and exhibited affinity toward bovine serum albumin (BSA). The complexes demonstrated promising cytotoxicity against lung cancer A549 cells, cisplatin-resistant lung cancer A549/DDP cells, cervical carcinoma HeLa cells and human liver carcinoma HepG2 cells, with IC50 values ranging from 9.98 to 19.63 μM. Unfortunately, these complexes had a low selectivity (selectivity index: 1.62-1.98) towards A549 cells and BEAS-2B normal cells. The charge pattern of the metal center (neutral or cationic) and ligand substituents showed little influence on the cytotoxicity and selectivity of these complexes. The study revealed that these complexes could target mitochondria, cause depolarization of the mitochondrial membrane, and trigger the production of intracellular ROS. Additionally, the complexes were observed to induce late apoptosis and perturb the cell cycle in the G2/M or S phase in A549 cells. Based on these results, it appears that the anticancer efficacy of these complexes was predominantly attributed to the redox mechanism.

Constructing anion–π interactions in cationic iridium(iii) complexes to achieve aggregation-induced emission properties

A design strategy used to develop AIE-active iridium(iii) complexes based on anion–π interactions is reported.

High-efficiency organic light-emitting diodes based on cationic iridium(iii) complexes with double tridentate ligands

Record-high device performance has been achieved with EQEmax over 17% by cationic tridentate Ir(iii) complexes.

Trifluoromethyl substituted cationic cyclometallated iridium(III) complexes: Photophysical properties and theoretical studies

Three new trifluoromethyl substituted (–CF3) cationic iridium(III) complexes 1–3, with 3,5-dimethyl-1-(3-(trifluoromethyl)phenyl)-1H-pyrazole (DTPP) as the cyclometallated ligand, namely, [Ir(DTPP)2bpy](PF6) (1, bpy = 2, 2′–bipyridine), [Ir(DTPP)2phen](PF6) (2, phen = 1,10-phenanthroline) and [Ir(DTPP)2pphen](PF6) (3, pphen = pyrazino[2,3-f][1,10]phenanthroline) have been rationally designed and synthesized in good yields (60–77%). The photophysical, electrochemical, and electroluminescent properties were fully characterized. Complexes 1–3 show bright blue to yellow emission in the both solution and neat film states with maximum emission wavelength in the range of 484–560 nm. Photoluminescence quantum yields (PLQYs) are very high ranging from 62% to 72% in the solution state with microsecond excited-state lifetimes (0.39–0.77 μs). More detailed photophysical and theortical calculation studies reveal that introduction of –CF3 substituent onto the cyclometallated ligand can induce a blue-shift emission compared with conventional fluorinated phenylpyridine or phenylpyrazole complexes, which can be contributed to the decline in HOMO energy level of complexes. Single-crystal structure analysis of complex 3 shows a distorted octahedral geometry with strong intermolecular π–π stacking (face-to-face) interactions between ancillary ligands in adjacent molecules, which might be responsible for the obviously red-shifted emission compared with complexes 1 and 2 in the aggregated state. In addition, electroluminescent properties of all three new complexes have been studied in the application of light-emitting electrochemical cells (LECs), which show green to yellow electroluminescence (λmax, EL = 516–540 nm).

Electrochemiluminescent silica nanoparticles encapsulating structure-optimized iridium complex to sensitively detect acetamiprid residues in tea based on aptamer sensor

To explore novel and efficient ECL luminophores, a series of cationic iridium(III) complexes with 4,7-diphenyl-1,10-phenanthroline as the ancillary ligand and various main ligands were investigated in this work. The comprehensive studies demonstrate complex 1, with 2-phenylbenzothiazole (bt) as main ligand, exhibited superior ECL properties in aqueous buffer compared to other complexes. Importantly, the structurally optimized complex 1 was successfully further encapsulated into silica nanoparticles to prepare electrochemiluminescent iridium(III)-doped silica nanoparticles (Ir@SiO2 NPs). These Ir@SiO2 NPs were then utilized to construct a sensitive and specific ECL aptamer sensor for detecting acetamiprid residues in tea. Notably, our developed sensor demonstrated wide linear ranges from 10 pM to 10 μM and low limit of detection of 1.3 pM. These experimental results presented in this work undoubtedly demonstrate iridium(III)-doped silica nanoparticles as a new and efficient type of ECL nano-emitter have great potentials in ECL-related analytical applications in the future.

Regulating energy gap in Ir-based ionic complexes to generate near-infrared emissions: Application in solid-state light-emitting electrochemical cells

Solid-state light-emitting electrochemical cells (LECs) exhibit high potential for commercial electronics owing to their simple solution-processable device architectures, low-voltage operation, and compatibility with inert metal electrodes. However, the low device efficiency of most deep-red and near-infrared (NIR) LECs hinders their application (external quantum efficiency (EQE) < 1.00%). In this study, we demonstrate a simple method to tune the energy gap between the highest occupied molecular orbital (HOMO) and the lowest unoccupied molecular orbital (LUMO) of iridium-based ionic transition metal complexes (iTMCs) to generate NIR emissions. We investigate a series of cationic iridium complexes with small energy gaps, with 2,2′-bibenzo[d]thiazole fixed as N^N ligand moiety mainly controlling the LUMO energy level, changing a series of C^N ligands. All complexes exhibited deep red/NIR phosphorescence, and these combined devices provided emission peaks at 690–730 nm and were applied as components in LECs, exhibiting a maximum EQE of 1.78% in electroluminescence devices. Using a host–guest emission system with the iridium complex YIr as the host and complex TBBI as the guest, the highest EQE of LECs could be further enhanced to>2.34%, which is the highest value reported for NIR LECs.

Understanding AIE and ACQ phenomenon of organometallic iridium(III) complexes by simple cationization engineering

Understanding the relationship between structure and properties is critical to the development of solid-state luminescence materials with desired characteristics and performance optimization. In this work, we elaborately designed and synthesized a pair of mononuclear iridium(III) complexes with similar structures but different degrees of cationization. [Ir2-f][2PF6] with two counterions is obtained by simple N-methylation of the ancillary ligand of [Ir1-f][PF6] which is a classic cationic iridium(III) complex. Such a tiny modification results in tremendously different optical properties in dilute solutions and powders. [Ir1-f][PF6] exhibits weak light in solution but enhanced emission in solid-state as well as poly(methyl methacrylate) matrix, indicative of its aggregation-induced emission (AIE) activity. On the sharp contrary, [Ir2-f][2PF6] is an aggregation-caused quenching (ACQ) emitter showing strong emission in the isolated state but nearly nonemissive in aggregation states. Benefiting from the appealing characteristics of mechanochromic luminescence and AIE behavior, [Ir1-f][PF6] has been successfully applied in reversible re-writable data recording and cell imaging. These results might provide deep insights into AIE and ACQ phenomenon of iridium(III) complexes and facilitate the development of phosphorescent materials with promising properties.

An AIE-active orange-emitting cationic iridium(III) complex for latent fingerprints detection via a simple powder dusting method

An AIE-active orange-emitting cationic iridium(III) complex for latent fingerprints detection via a simple powder dusting method

Unveiling the Latent Reactivity of Cp* Ligands (C5Me5-) toward Carbon Nucleophiles on an Iridium Complex.

The divergent reactivity of the cationic iridium complex [(η5-C5Me5)IrCl(PMe2ArDipp2)]+ (ArDipp2 = C6H3-2,6-(C6H3-2,6-iPr2)2) toward organolithium and Grignard reagents is described. The noninnocent behavior of the Cp* ligand, a robust spectator in the majority of stoichiometric and catalytic reactions, was manifested by its unforeseen electrophilic character toward organolithium reagents LiMe, LiEt, and LinBu. In these unconventional transformations, the metal center is only indirectly involved by means of the Ir(III)/Ir(I) redox cycle. In the presence of less nucleophilic organolithium reagents, the Cp* ligand also exhibits noninnocent behavior undergoing facile deprotonation, which is also concomitant with the reduction of the metal center. In turn, the weaker alkylating agents EtMgBr and MeMgBr effectively achieve the alkylation of the metal center. These reactive iridium(III) alkyls partake in subsequent reactions: while the ethyl complex undergoes β-H elimination, the methyl derivative releases methane by a remote C-H bond activation. Computational studies, including the quantum theory of atoms in molecules (QTAIM), support that the preferential activation of the non-benzylic C-H bonds takes place via sigma-bond metathesis.

Cationic Ir(III) Complex with 5-Phenyl-1H-1,2,4-triazole and 2-(1-Pyrazolyl)pyridine Derivatives for Blue Light-emitting Electrochemical Cells

Cationic iridium complex for blue light-emitting electrochemical cells (LECs) was synthesized from 1-(2,6-dimethylphenyl)-3-methyl-5-phenyl-1H-1,2,4-triazole (dphtz) cyclometalating ligand and 2-(1-phenyl-1H-pyrazol-3-yl)pyridine (phpzpy) ancillary ligand. The photophysical and electrochemical properties were investigated by UV-vis absorption, photoluminescence spectroscopy and cyclic voltammetry, and compared to those of the previously reported [Ir(ppy)2(phpzpy)]+. The LECs emitted blue light peaking around 488 nm and max luminance of 77.35 cd/m2 under constant current density of 10 mA/cm2.

Dinuclearization strategy of cationic iridium(iii) complexes for efficient and stable flexible light-emitting electrochemical cells

A simple and feasible di-nuclearization strategy of organometallic iridium(iii) complex used to achieve high-efficiency and long-lasting flexible light-emitting electrochemical cells concurrently is demonstrated.

Cationic Iridium(III) Complexes with Benzothiophene-Quinoline Ligands for Deep-Red Light-Emitting Electrochemical Cells.

Three new cationic cyclometalated iridium(III) complexes equipped with differently substituted benzo[b]thiophen-2-ylquinoline cyclometalating ligands and with a sterically demanding tert-butyl-substituted 2,2'-bipyridine ancillary ligand were synthesized and structurally characterized by NMR and X-ray diffraction techniques. To tune the electronic properties of such complexes, the quinoline moiety of the cyclometalating ligands was kept pristine or equipped with electron-withdrawing phenyl and -CF3 substituents, leading to complexes 1, 2, and 3, respectively. A complete electrochemical and photophysical investigation, supported by density functional theory calculations, permits a deep understanding of their electronic properties. The emission of all complexes arises from ligand-centered triplet states in the spectral range between 625 and 950 nm, with excited-state lifetimes between 2.10 and 6.32 μs at 298 K. The unsubstituted complex (1) exhibits the most blue-shifted emission in polymeric matrix at 298 K (λmax = 667 nm, photoluminescence quantum yield (PLQY) = 0.25 and τ = 5.32 μs). The phenyl-substituted complex (2) displays the highest photoluminescent quantum yields (up to 0.30 in polymeric matrix), while the CF3-substituted counterpart (3) shows the most red-shifted emission, peaking at approx. 720 nm, but with lower quantum yields (e.g., 0.10 in polymeric matrix at 298 K). Complexes 1 and 2 were tested in single-layer nondoped light-emitting electrochemical cells (LEECs), using a nozzle-printing technique; both devices display deep-red electroluminescence with an external quantum efficiency close to 20%.